Skip to main content
. 2010 Nov 3;5(11):e15391. doi: 10.1371/journal.pone.0015391

Table 1. Mean % antibody depletion from DiCo 1, 2 and 3-coated plates.

Capture antigen Competitor antigen Gp 1 (7Ag/HT) n = 9 Gp 2 (3Ag/HT) n = 8 Gp 3 (3Ag/IMS) n = 8 Gp 4 (3Ag/ISA 51) n = 5
DiCo 1 FVO 84.7(81.6–87.8) 83.0(79.5–86.6) 77.0(71.9–82.0) 77.4(73.0–81.8)
HB3 93.9(91.7–96.1) 90.1(88.5–91.6) 90.7(87.9–93.6) 83.4(76.7–90.1)
DM 96.1(93.9–98.3) 98.6(98.2–99.1) 97.2(95.9–98.4) 91.9(88.3–95.5)
CAMP 87.6(84.2–90.9) 86.3(84.5–88.0) 78.3(74.5–82.1) 77.4(71.4–83.5)
3D7 75.2(72.2–78.2) 76.9(73.1–80.8) 69.3(65.0–73.6) 61.4(54.9–68.0)
NM 97.6(96.1–99.0) 92.4(91.3–93.4) 92.1(90.8–93.5) 88.2(85.8–90.6)
DiCo 2 FVO 90.0(87.2–92.8) 86.4(84.2–88.6) 84.8(79.4–90.2) 83.6(81.2–86.1)
HB3 94.0(91.8–96.2) 94.4(91.1–97.8) 97.1(94.8–99.4) 83.7(71.6–95.7)
DM 96.1(93.9–98.4) 97.6(96.4–98.9) 98.1(96.6–99.6) 92.9(90.4–95.5)
CAMP 83.0(79.6–86.4) 83.5(80.1–87.0) 77.9(75.3–80.5) 77.3(76.1–78.6)
3D7 67.6(63.3–71.9) 68.3(65.9–70.6) 63.6(58.7–68.5) 56.6(48.3–64.9)
NM 95.0(93.7–96.4) 92.9(91.2–94.7) 95.0(92.2–97.8) 88.9(85.5–92.3)
DiCo 3 FVO 81.2(77.7–84.6) 81.9(78.2–85.6) 72.8(66.9–78.7) 74.1(66.8–81.4)
HB3 91.9(89.6–94.3) 87.1(85.2–88.9) 85.1(82.5–87.7) 80.9(74.8–87.0)
DM 97.3(92.2–102.2) 97.8(96.4–99.3) 96.8(95.4–98.2) 91.0(89.1–92.9)
CAMP 80.2(77.0–83.3) 80.8(76.7–84.9) 66.3(59.7–73.0) 67.8(62.5–73.1)
3D7 82.1(78.6–85.6) 80.6(77.9–83.2) 66.5(61.4–71.7) 57.8(47.9–67.6)
NM 94.2(93.1–95.4) 91.4(89.0–93.7) 86.5(83.6–89.4) 84.0(77.6–90.4)

Antibody depletion after competition ELISA, values reported as mean % depletion (95%CI).

7Ag – vaccine containing DiCo mix + four AMA1 alleles from FVO, HB3, 3D7 and CAMP parasite strains.

3Ag – vaccine containing DiCo mix.

NM &DM – competitor antigen mixtures comprising natural AMA1 alleles (FVO, HB3, 3D7, CAMP) and DiCo mix, respectively.